Krystal Biotech Cash Flow Statement (2021-2026) | KRYS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-16.36M	-15.59M	-21.81M	-49.97M	-28.11M	-29.85M	-32.05M	-45.30M	-33.21M	80.75M	8.69M	0.93M	15.57M	27.17M	45.51M	35.73M	38.33M	79.37M	51.39M	55.93M
Depreciation and Depletion (Quarter)	0.47M	0.47M	0.40M	0.46M	0.49M	0.67M	1.00M	1.10M	1.20M	1.20M	1.52M	1.40M	1.80M	1.30M	1.40M	1.40M	1.30M	1.40M	1.56M	1.52M
Share-based Compensation (Quarter)	4.20M	3.67M	5.14M	6.43M	8.19M	9.06M	9.55M	10.44M	11.33M	8.31M	9.85M	9.30M	13.16M	13.32M	13.36M	13.48M	14.12M	13.15M	13.76M	13.61M
Deferred Taxes (Quarter)																			-1.83M
Gains from Investment Securities (Quarter)	1.49M			0.65M	-0.66M	0.66M	-0.65M	0.81M	1.58M	1.50M	-3.89M	1.21M	1.65M	-2.86M		1.80M	-0.01M		4.16M	0.53M
Cash from Operations (Quarter)	-10.13M	-7.25M	-20.90M	-15.49M	-43.06M	-19.69M	-22.33M	-26.16M	-34.19M	-21.23M	-7.23M	15.89M	-4.17M	58.86M	52.84M	30.97M	52.73M	39.66M	77.51M	80.38M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)								0.22M	0.22M	0.23M	0.23M	0.18M	0.19M	0.19M	0.19M	0.22M	0.19M	0.21M	0.20M	0.20M
Depreciation & Amortization (CF) (Quarter)	0.67M	0.78M	0.78M	1.01M	0.98M	0.97M	1.09M	0.70M	1.04M	0.83M	1.52M	1.40M	1.80M	1.30M	1.40M	1.40M	1.30M	1.40M	1.56M	1.52M
Change in Working Capital
Change in Receivables (Quarter)										9.32M	32.72M	4.43M	56.77M	-5.94M	7.45M	-1.49M	8.18M	17.92M	-2.49M	-0.06M
Change in Inventory (Quarter)									0.91M	3.08M	0.49M	2.24M	-0.53M	3.68M	6.52M	1.40M	-0.88M	4.71M	1.06M	0.24M
Change in Account Payables (Quarter)	-0.97M	0.46M	0.94M	-0.55M	0.58M	-0.34M	-0.94M	0.11M	0.37M	-0.36M	-0.22M	0.73M	0.78M	0.09M	-0.59M	0.91M	4.12M	-4.02M	-0.18M	1.02M
Change in Accured Expenses (Quarter)	2.52M	3.93M	-4.02M	2.01M	0.46M	0.54M	2.16M	-3.46M	1.80M	2.54M	3.68M	-5.16M	1.13M	1.94M	7.48M	3.69M	-1.29M	5.92M	5.79M	-6.31M
Change in Taxes (Quarter)															0.97M				2.29M	-3.37M
Other Working Capital Changes (Quarter)	-1.38M	0.33M	1.73M	-0.14M	-0.71M	-0.18M	1.65M	0.00M	0.05M	-0.13M	0.29M	-0.24M	0.33M	0.67M	-0.11M	0.61M	0.08M	1.03M	0.55M	0.14M
Investing Activities
Capital Expenditures (Quarter)	3.85M	16.75M	45.12M	14.51M	7.73M	25.53M	-32.84M	5.38M	5.62M	0.10M	0.70M	1.26M	1.13M	1.05M	5.06M	1.40M	6.71M	-7.49M	2.44M	7.15M
Sales of Property, Plant and Equipment (Quarter)																0.43M
Change in Acquisitions & Divestments (Quarter)	1.23M	8.07M	21.00M	24.04M	62.79M	66.77M	104.08M	154.52M	161.23M	112.87M	74.59M	63.62M	95.18M	79.25M	60.49M	88.81M	105.28M	95.79M	85.76M	103.60M
Cash from Investing Activities (Quarter)	-62.32M	-37.17M	-126.54M	-55.91M	-38.22M	-14.74M	-5.21M	3.56M	-15.96M	105.19M	-10.16M	-25.98M	-19.35M	-34.33M	-83.78M	-54.77M	-10.53M	-4.29M	11.16M	-63.58M
Financing Activities
Cash from Financing Activities (Quarter)	-0.20M	1.51M	202.07M	-0.54M	30.70M	2.12M	3.07M	1.47M	185.27M	13.39M	2.62M	10.58M	10.64M	3.37M	2.43M	-12.47M	1.80M	3.71M	15.67M	-10.46M
Additional items
Exchange Rate Effect (Quarter)							-0.04M	-0.04M	0.01M	0.01M	-0.14M	0.19M	-0.34M	0.29M	-0.59M	0.17M	1.06M	-0.31M	-0.64M	-1.33M
Change in Cash (Quarter)	-72.64M	-42.91M	54.63M	-71.94M	-50.58M	-32.31M	-24.51M	-21.16M	135.13M	97.37M	-14.91M	0.68M	-13.22M	28.18M	-29.10M	-36.09M	45.06M	38.77M	103.70M	5.01M
Free Cash Flow (Quarter)	-13.98M	-24.01M	-66.02M	-30.00M	-50.79M	-45.22M	10.51M	-31.54M	-39.81M	-21.33M	-7.93M	14.63M	-5.30M	57.81M	47.78M	29.57M	46.02M	47.14M	75.06M	73.23M
Net Cash Flow (Quarter)	-72.64M	-42.91M	54.63M	-71.94M	-50.58M	-32.31M	-24.47M	-21.12M	135.12M	97.35M	-14.77M	0.49M	-12.88M	27.89M	-28.51M	-36.27M	44.00M	39.08M	104.34M	6.34M

Research Tools

Krystal Biotech Cash Flow Statement (2021-2026) | KRYS

Create an account

Sign In

Reset Password